sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Blood Coagulants Market Scope And Analysis

  • Report Code : TIPRE00004416
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dei coagulanti del sangue e dei concorrenti entro il 2025-2031

Buy Now

Blood Coagulants Market Report Blood Coagulants Market Size and Share Blood Coagulants Market Scope and Analysis

Blood Coagulants Market Report Scope

Report Attribute Details
Market size in XX milioni di dollari USA nel 2024
Market Size by XX milioni di dollari entro il 2031
Global CAGR ()
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Classe di farmaci
  • anticoagulanti orali non-VKA
  • eparina ed eparina a basso peso molecolare
  • antagonisti della vitamina K
  • altri
By Via di somministrazione
  • orale
  • iniettabile
By Tipo di disturbo emorragico
  • emofilia A
  • emofilia B
  • malattia di von Willebrand
  • altri
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Aspen Holdings
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Baxter International Inc.
  • Daiichi Sankyo Company
  • Grifols International SA, Limited
  • GlaxoSmithKline Plc.
  • Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
  • Novo Nordisk A/S